United States Anastomosis Assist Devices Market 2018

News provided by

Research and Markets

09 Jan, 2018, 14:00 GMT

DUBLIN, Jan. 9, 2018 /PRNewswire/ --

The "US Market Report for Anastomosis Assist Devices 2018 - MedCore" report has been added to Research and Markets' offering.

The traditional and most common method of performing anastomosis typically involves tedious and time-consuming hand-sewn placement of individual stitches with a continuous suture to connect the bypass graft proximally to the aorta and distally to the coronary vessels. Anastomosis is viewed by surgeons as the most critical step in performing CABG procedures, and using traditional methods, the process can take 10 to 25 minutes to perform the necessary suture for each point of anastomosis. Most surgeons prefer to use a continuous suture because placement of sutures individually is considered to be more challenging and time-consuming. Whether the procedure is on-pump or off-pump, hand-sewn proximal anastomosis generally requires clamping of the aorta, which carries the risk of neurological damage and other serious adverse effects.

Anastomosis assist devices (AADs) are used for joining two blood vessels, usually to restore continuity after resection, or to bypass an unresectable disease process. Coronary artery bypass graft (CABG) involves the construction of an alternative path to bypass a narrowed or occluded diseased coronary artery and restore blood flow from the aorta to an area beyond the occlusion. This is accomplished by using harvested veins or arteries as bypass grafts. This harvested vessel is usually the saphenous vein in the leg, the radial artery in the arm or the mammary artery from the chest wall. One end of the harvested vessel is then generally attached to the aorta (proximal anastomosis) and the opposite end is attached to the target coronary vessel on the heart (distal anastomosis).

If the mammary artery is used as the bypass graft, it is dissected from the chest wall, leaving the blood inflow end in place, while the opposite dissected end is attached to the target vessel. This provides uninterrupted blood flow and eliminates the need for proximal anastomosis to the aorta. Regardless of the type of vessel used, once in place, these grafts provide sufficient blood flow to bypass the narrowed or occluded portion of the coronary artery.

Key Topics Covered:

Executive Summary

1. Research Methodology

2. Disease Overview

3. Product Portfolio

4. Anastomosis Assist Device Market

Companies Mentioned

  • Edwards Lifesciences
  • St. Jude Medical
  • Medtronic
  • Maquet
  • Abiomed
  • HeartWare Inc.
  • Sorin Group
  • Terumo
  • Abbott Laboratories
  • Teleflex Medical
  • Cardiac Assist
  • AtriCure
  • W.L. Gore
  • SynCardia
  • Boston Scientific
  • Cryolife
  • Berlin Heart
  • Cardica
  • Chase Medical
  • Genesee Biomedical
  • Karl Storz
  • LifeNet Health
  • Microline Surgical
  • Novadaq
  • On-X
  • Saphena Medical
  • SentreHeart
  • Vitalitec

For more information about this report visit https://www.researchandmarkets.com/research/b4gxxb/united_states?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com